Mandate

Vinge has advised Gränges on the refinancing of its sustainability-linked credit facility

February 10, 2025 Banking and Finance

Vinge has advised Gränges AB (publ) (“Gränges”), a global leader in aluminium rolling and recycling in selected niches, on the refinancing of its sustainability-linked credit facility, which supports Gränges’ sustainability plan.

The credit facility, arranged by Danske Bank, Nordea, SEB, and Citibank, consists of a revolving credit facility of SEK 3,000 million (with an option to increase to SEK 3,500 million) and a term facility of USD 70 million. The agreement has a three-year term, with the possibility of a two-year extension.

The financing is linked to the performance of two sustainability key performance indicators (KPIs) tied to Gränges’ climate targets, which are also reflected in the company’s sustainability-linked financing framework. The new agreement is expected to contribute with reduced financing costs and further strengthen Gränges’ sustainability profile. As part of the refinancing, the 2022 credit facility has been repaid.

Vinge’s team consisted of Helena Göransson and Karl-Gustaw Tobola (Banking & Finance).

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025